LU86173A1 - Moyen de diagnostic rapide pour le groupage sanguin et procede pour sa preparation - Google Patents
Moyen de diagnostic rapide pour le groupage sanguin et procede pour sa preparation Download PDFInfo
- Publication number
- LU86173A1 LU86173A1 LU86173A LU86173A LU86173A1 LU 86173 A1 LU86173 A1 LU 86173A1 LU 86173 A LU86173 A LU 86173A LU 86173 A LU86173 A LU 86173A LU 86173 A1 LU86173 A1 LU 86173A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- reagents
- blood
- diagnostic means
- rapid diagnostic
- preparation
- Prior art date
Links
- 210000004369 blood Anatomy 0.000 title claims description 35
- 239000008280 blood Substances 0.000 title claims description 34
- 238000000034 method Methods 0.000 title claims description 10
- 238000002360 preparation method Methods 0.000 title claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 34
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 13
- 229910052782 aluminium Inorganic materials 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 9
- 230000004520 agglutination Effects 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 5
- 210000002381 plasma Anatomy 0.000 claims description 5
- 108010049003 Fibrinogen Proteins 0.000 claims description 4
- 102000008946 Fibrinogen Human genes 0.000 claims description 4
- 229940012952 fibrinogen Drugs 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 3
- 238000000151 deposition Methods 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 claims 1
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 10
- 239000011888 foil Substances 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
- 108090000526 Papain Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 229960002900 methylcellulose Drugs 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 229940055729 papain Drugs 0.000 description 3
- 235000019834 papain Nutrition 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000001291 vacuum drying Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920001917 Ficoll Polymers 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 2
- 229940052299 calcium chloride dihydrate Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 1
- 101100114416 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) con-10 gene Proteins 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000910 agglutinin Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940078480 calcium levulinate Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000185 hemagglutinin Substances 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000029305 taxis Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/553—Metal or metal coated
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Inorganic Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU435884A HU192513B (en) | 1984-11-23 | 1984-11-23 | Quick diagnostic substance for determining blood group |
| HU435884 | 1984-11-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU86173A1 true LU86173A1 (fr) | 1986-03-24 |
Family
ID=10967746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU86173A LU86173A1 (fr) | 1984-11-23 | 1985-11-21 | Moyen de diagnostic rapide pour le groupage sanguin et procede pour sa preparation |
Country Status (14)
| Country | Link |
|---|---|
| AT (1) | AT390845B (cs) |
| BE (1) | BE903684A (cs) |
| BG (1) | BG46009A3 (cs) |
| CH (1) | CH664833A5 (cs) |
| CS (1) | CS268806B2 (cs) |
| DE (1) | DE3541355A1 (cs) |
| FR (1) | FR2573873B1 (cs) |
| GB (1) | GB2167856B (cs) |
| HU (1) | HU192513B (cs) |
| LU (1) | LU86173A1 (cs) |
| NL (1) | NL8503186A (cs) |
| RO (1) | RO92914B (cs) |
| RU (1) | RU1830143C (cs) |
| YU (1) | YU45749B (cs) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2129281C1 (ru) * | 1998-05-14 | 1999-04-20 | Зотиков Евгений Алексеевич | Идентификационные полоски для экспресс теста на индивидуальную совместимость крови донора и реципиента |
| EP3694322B1 (en) | 2017-10-09 | 2024-07-03 | Terumo BCT Biotechnologies, LLC | Lyophilization container and method of using same |
| US11604026B2 (en) | 2019-03-14 | 2023-03-14 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3502437A (en) * | 1967-03-13 | 1970-03-24 | Haematronics Inc | Identification card |
| US3990850A (en) * | 1976-01-06 | 1976-11-09 | Akzona Incorporated | Diagnostic test card |
| US4055394A (en) * | 1976-10-18 | 1977-10-25 | Akzona Incorporated | Diagnostic test card |
| DE2938009A1 (de) * | 1979-09-20 | 1981-04-30 | Ernst Dr. 5300 Bonn Cohnen | Serco-spezial-tuepfelplatte zur blutgruppenbestimmung |
| DE8029596U1 (de) * | 1980-11-06 | 1981-06-11 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Blutgruppenidentitaetskarte, insbesondere fuer den bed side-test |
| DE8137962U1 (de) * | 1981-12-28 | 1982-06-16 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Mikrotiterplatte zur blutgruppendiagnostik |
| DE3323645A1 (de) * | 1983-07-01 | 1985-01-10 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Diagnostisches testsystem |
| GB8423204D0 (en) * | 1984-09-14 | 1984-10-17 | Comtech Res Unit | Assay technique and equipment |
-
1984
- 1984-11-23 HU HU435884A patent/HU192513B/hu not_active IP Right Cessation
-
1985
- 1985-11-18 GB GB08528364A patent/GB2167856B/en not_active Expired
- 1985-11-19 NL NL8503186A patent/NL8503186A/nl not_active Application Discontinuation
- 1985-11-20 CS CS858383A patent/CS268806B2/cs unknown
- 1985-11-20 CH CH495585A patent/CH664833A5/de not_active IP Right Cessation
- 1985-11-21 LU LU86173A patent/LU86173A1/fr unknown
- 1985-11-21 BE BE0/215896A patent/BE903684A/fr not_active IP Right Cessation
- 1985-11-21 AT AT339285A patent/AT390845B/de not_active IP Right Cessation
- 1985-11-21 FR FR8517245A patent/FR2573873B1/fr not_active Expired
- 1985-11-22 RO RO120880A patent/RO92914B/ro unknown
- 1985-11-22 YU YU182085A patent/YU45749B/sh unknown
- 1985-11-22 DE DE19853541355 patent/DE3541355A1/de not_active Ceased
- 1985-11-22 BG BG072466A patent/BG46009A3/xx unknown
- 1985-11-22 RU SU853987366A patent/RU1830143C/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| CH664833A5 (de) | 1988-03-31 |
| GB8528364D0 (en) | 1985-12-24 |
| AT390845B (de) | 1990-07-10 |
| HU192513B (en) | 1987-06-29 |
| GB2167856B (en) | 1988-12-21 |
| BE903684A (fr) | 1986-03-14 |
| RU1830143C (ru) | 1993-07-23 |
| RO92914B (ro) | 1987-12-01 |
| BG46009A3 (en) | 1989-09-15 |
| RO92914A (ro) | 1987-11-30 |
| YU45749B (sh) | 1992-07-20 |
| CS268806B2 (en) | 1990-04-11 |
| FR2573873B1 (fr) | 1988-09-09 |
| GB2167856A (en) | 1986-06-04 |
| YU182085A (en) | 1990-08-31 |
| CS838385A2 (en) | 1989-08-14 |
| DE3541355A1 (de) | 1986-06-19 |
| NL8503186A (nl) | 1986-06-16 |
| HUT39516A (en) | 1986-09-29 |
| ATA339285A (de) | 1989-12-15 |
| FR2573873A1 (fr) | 1986-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tornvall et al. | Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction | |
| Salaspuro | Use of enzymes for the diagnosis of alcohol-related organ damage | |
| Salonen et al. | Serum copper and the risk of acute myocardial infarction: a prospective population study in men in eastern Finland | |
| Maser et al. | Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Pittsburgh Epidemiology of Diabetes Complications Study-V. | |
| Schleicher et al. | Increased accumulation of the glycoxidation product N (epsilon)-(carboxymethyl) lysine in human tissues in diabetes and aging. | |
| Iribarren et al. | Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study | |
| Zoccali et al. | Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease | |
| Pickup et al. | Serum sialic acid concentration and coronary heart disease in NIDDM | |
| CA2366309C (en) | Method and device for detection of apo a, apo b and the ratio thereof in saliva | |
| BLANKENHORN et al. | Ischemic heart disease in young adults: metabolic and angiographic diagnosis and the prevalence of type IV hyperlipoproteinemia | |
| Peterson et al. | Comparison of gamma-glutamyltransferase and other health screening tests in average middle-aged males, heavy drinkers and alcohol non-users | |
| Jerums et al. | Relationship of progressively increasing albuminuria to apoprotein (a) and blood pressure in type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetic patients | |
| Ordene et al. | Variable thyrotropin response to thyrotropin-releasing hormone after small decreases in plasma thyroid hormone concentrations in patients of advanced age | |
| Hofmann et al. | Enhanced degradation of platelet-activating factor in serum from diabetic patients | |
| LU86173A1 (fr) | Moyen de diagnostic rapide pour le groupage sanguin et procede pour sa preparation | |
| WO2001002864A1 (fr) | Methodes et kits pour le diagnostic ou le suivi d'une pathologie synoviale ou osteoarticulaire comprenant l'utilisation d'un marqueur specifique de la degradation du tissu synovial | |
| Figueredo et al. | Plasma C3d levels and ischemic heart disease in type II diabetes | |
| CH713752B1 (fr) | Méthode d'identification d'écarts à la norme d'indices de l'urine. | |
| UK Prospective Diabetes Study Group | UK Prospective Diabetes Study (UKPDS) X. Urinary albumin excretion over 3 years in diet-treated Type 2,(non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia | |
| Turk et al. | Products of advanced glycation in patients with type 2 diabetes and vascular disease | |
| JP2002528722A5 (cs) | ||
| GB2173306A (en) | The determination of albumin and a carrier and fixation technique usable therein | |
| Hoeg et al. | Initial diagnosis of lipoprotein lipase deficiency in a 75-year-old man | |
| Krut, LH, Seftel, HC & Joffe | Comparison of clofibrate with halofenate in diabetics with hyperlipidaemia | |
| Pedersen et al. | Urinary excretion of albumin β2-microglobulin and free light chains during lithium treatment |